The largest database of trusted experimental protocols

Plasmid maxi kit

Manufactured by Qiagen
Sourced in Germany, United States, United Kingdom, Japan, China

The Plasmid Maxi Kit is a laboratory product designed for the isolation and purification of high-quality plasmid DNA from bacterial cultures. It is a tool used in molecular biology and genetic engineering research.

Automatically generated - may contain errors

278 protocols using plasmid maxi kit

1

Determination of DfCas9 PAM Sequence

Check if the same lab product or an alternative is used in the 5 most similar protocols
To determine DfCas9 PAM sequence a randomized 7N plasmid library carried a protospacer sequence flanked by seven randomized nucleotides was used (Supplementary Table S1). To create the library the ssDNA oligo Library_F containing randomized nucleotides was double-stranded through single stage PCR with Library_R primer (Evrogen). This fragment was assembled with PUC19 fragment synthesized through PCR using primers PUC19_F and PUC19_R by NEBuilder HiFi DNA Assembly Cloning Kit (NEB, E5520). The mix was transformed to Escherichia coli DH5alpha strain and plated to media supplemented with 100 μg/ml ampicillin. The plates were incubated at 37°C. Eighteen hours after transformation more than 50 000 colonies were washed off the plates, and the plasmid library was extracted by Qiagen Plasmid Maxi kit (Qiagen 12162). The library plasmid map is presented in the Supplementary Table S1. Competent E. coli Star cells carrying pACYC184_DfCas9_locus or an empty pACYC184 vector were transformed with 7N PAM plasmid libraries and plated to 100 μg/ml ampicillin and 25 μg/ml chloramphenicol containing agar plates. After 16 h cells were harvested and DNA was extracted using Qiagen Plasmid Maxi kit (Qiagen 12162). PAM-coding sequences were PCR amplified using M13_f and M13_r primers and sequenced using Illumina platform with pair-end 150 cycles (75+75).
+ Open protocol
+ Expand
2

Construction and characterization of 7N plasmid libraries

Check if the same lab product or an alternative is used in the 5 most similar protocols
Randomized 7N plasmid libraries carried a protospacer sequence flanked by seven randomized nucleotides (Supplementary Table S1). To create the library the ssDNA oligo Library_f containing randomized nucleotides was double-stranded through single stage PCR with Library_r primer (Evrogen). This fragment was assembled with PUC19 fragment synthesized through PCR using primers PUC19_F and PUC19_R by NEBuilder HiFi DNA Assembly Cloning Kit (NEB, E5520). The mix was transformed to Escherichia coli DH5alpha strain and plated to media supplemented with 100 μg/ml ampicillin. The plates were incubated at 37°C. Eighteen hours after transformation >50 000 colonies were washed off the plates, and the plasmid library was extracted by Qiagen Plasmid Maxi kit (Qiagen 12162). HTS analysis of the library showed representation of 15716 PAM variants. The library plasmid map is presented in the Supplementary Table S1. Competent E. coli Star cells carrying pACYC184_CcCas9_locus or an empty pACYC184 vector were transformed with 7N PAM plasmid libraries and plated to 100 μg/ml ampicillin and 25 μg/ml chloramphenicol containing agar plates. After 16 h, cells were harvested and DNA was extracted using Qiagen Plasmid Maxi kit (Qiagen 12162). PAM-containing sequences were PCR amplified using M13_f and M13_r primers and sequenced using Illumina platform with pair-end 150 cycles (75 + 75).
+ Open protocol
+ Expand
3

Minicircle Plasmid Production and Purification

Check if the same lab product or an alternative is used in the 5 most similar protocols
The minicircle plasmids were produced as described previously6 (link)12 (link). The episomal reprogramming plasmids used for this study were purified using the QIAGEN Plasmid Maxi Kit (QIAGEN, USA). The 4-in-1 CoMiP construct was transformed into NTC4862 DH5α competent cells and then plated on 6% sucrose solid media (see Nature Technology's NTC vector User's Manual) and propagated at 30°C for 24–48 hours. Individual colonies were picked and miniprep was performed (QIAprep Spin Miniprep Kit, USA). Thereafter, a 100 μl aliquot of the 4-in-1 CoMiP bacterial culture was inoculated with 100 ml of 6% sucrose liquid media and incubated for 16–18 hr at 37°C. This culture was then used to isolate the 4-in-1 CoMiP vector by using the QIAGEN Plasmid Maxi Kit.
+ Open protocol
+ Expand
4

Plasmid Isolation and Quantification

Check if the same lab product or an alternative is used in the 5 most similar protocols
The pOVAs were amplified from previously transformed stocks of Escherichia coli DH5α using antibiotic-selective conditions. After amplification of the E. coli, the plasmids were isolated and purified by using QIAGEN Plasmid Maxi Kits. The quality and quantity of the purified pOVA were evaluated by the optical density at 260 and 280 nm.
+ Open protocol
+ Expand
5

Generating Infectious cDNA Clones

Check if the same lab product or an alternative is used in the 5 most similar protocols
Full-length cDNA materials encoding C15, C2, C41 and A16 (pR16.11) infectious genomes have been described (Lee & Wang, 2003 (link); Bochkov et al., 2011 (link); Nakagome et al., 2014 (link)). pR16.939 encodes an RV-A16 clinical isolate that was cloned and provided by Dr. Wai-Ming Lee (Biological Mimetic Inc). The adaptive point mutations in C15, C2 and C41 infectious clones were engineered by conventional site-directed mutagenesis using the appropriate flanking primers with unique restriction enzyme sites and internal overlapping primers with mutated bases (Table S1) in a two-step PCR method. Adaptive mutations in the A16 clone (pR16.939) were made by linking the purified PCR2 product (Fig.6B) and pR16.939 clone digested with EcoRV and SnaBI using NEBuilder HiFi DNA Assembly Master Mix (NEB). A total of four cDNA clones containing individual mutations (M1, M4) or various linked combinations (M2, M3) were selected. All plasmid DNAs were verified in the regions of interest by sequencing, and then purified by Plasmid Maxi kits (Qiagen) before use in RNA synthesis reactions with T7 polymerase (Promega).
+ Open protocol
+ Expand
6

Lentiviral knockdown of DISC1 gene

Check if the same lab product or an alternative is used in the 5 most similar protocols
The shRNA sequence used to knock down endogenous DISC1 was: 5′-GGCAAACACTGTGAAGTGC-3′ (refs 21 (link), 33 (link), 34 (link), 35 (link)). This hairpin fragment was subcloned into a lentiviral vector previously used by our group32 (link). Oligonucleotides containing the shRNA sequence were synthesized, annealed and digested using XhoI and EcoRI for insertion into a published AAV construct containing a floxed-stop codon cassette to allow Cre-dependent shRNA expression63 (link). Following ligation, One Shot Stbl3 Chemically Competent E. Coli (Invitrogen) were transformed and spread on Luria Bertani agar plates containing ampicillin to select positive colonies. Plasmid DNA for all viral constructs was prepared using Endofree Plasmid Maxi kits (Qiagen). All plasmids for transfection into HEK-293 cells were prepared using Plasmid Maxi kits (Qiagen).
+ Open protocol
+ Expand
7

Influenza A/California/7/2009 (H1N1) RNA Replicon Formulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
RNA was prepared as previously reported (33 (link), 34 (link)). Briefly, the H1 gene was amplified from the cDNA of the influenza virus A/California/7/2009 (H1N1) and cloned as SalI and NotI fragments into an optimized replicon construct. DNA plasmid encoding the H1 replicon was amplified in Escherichia coli, and purified using Plasmid Maxi kits (Qiagen). DNA was linearized immediately downstream of the 3’-end of the SAM sequence by endonuclease restriction digestion with Pmel. The linearized DNA Templates were purified by phenol/choloroform extraction and ethanol precipitation before being transcribed into RNA using MEGAscript T7 kit (LifeTechnologies). The RNA was capped using ScriptCap m7G Capping system (CellScript), purified by LiCl precipitation and suspended in nuclease-free water (LifeTechnology). SAM-H1 RNA integrity was evaluated on an 1% agarose-LE gel (Ambion). SAM-H1 RNA was formulated with CNE (35 (link)) prepared as previously reported (18 (link), 35 (link), 36 (link)). The RNA was added in a drop wise manner to an equal volume of CNE. The formulation was complexed for 45 min on ice and prepared fresh for each immunization. The particle size of the complex was measured by dynamic light scattering (Malvern) to 194 ± 76nM and injected within 2 h of preparation.
+ Open protocol
+ Expand
8

Transient Silencing of CSIG Using siRNA

Check if the same lab product or an alternative is used in the 5 most similar protocols
The pcDNA3.1-CSIG and control vectors were purified with QIAGEN Plasmid Maxi Kits. Cells were transfected with plasmids coated by Lipofectamine 2000 (Invitrogen) following the manufacturer’s indications. To transiently silence CSIG, siRNA targeting CSIG (siCSIG) and control siRNA were synthesized (Genema), respectively. siRNAs were transfected with Lipofectamine 2000 (Invitrogen) following the manufacturer’s recommendations. Cells were collected 48 h after transfection for further analysis. The siRNA sequences were as follows:

CSIG siRNA: 5′-AGAAGGAACAGACGCCAGA-3′

Control siRNA: 5′-TTCTCCGAACGTGTCACGT-3′

+ Open protocol
+ Expand
9

Recombinant Peptide Expression in P. pastoris

Check if the same lab product or an alternative is used in the 5 most similar protocols
Nucleotide sequence of peptides were designed as 6XHis-tagged recombinant peptides between the sequences of PR-PPD and buforin2. Eco RI and Pst I restriction sites were added to the N-terminal and C-terminal of peptide sequences, respectively. These sequences were synthesized and cloned into the pUC19 plasmid vector (GeneArt/Thermo Fisher, USA). Purified BR2-PPD, BR2-2xPPD and BR2-2xΔPPD peptides were ligated into the modified pPICZαA expression vector (Invitrogen/Thermo Fisher, USA) and transformed into DH5α competent E. coli (New England Biolab, USA). Cells were grown on low salt LB agar plates containing 25 µg/ml Zeocin (Invitrogen/Thermo Fisher, USA) and incubated at 37°C overnight. pPICZαA recombinant plasmids were extracted and purified by Plasmid Maxi kits (Qiagen, Germany).
Purified recombinant plasmids were linearized by Sac I and transformed into the P. pastoris strain KM71H competent cells by electroporation. Cells were selected on YPD plates containing 100 μg/ml Zeocin. Yeast genomic DNA were extracted (Zymo research, USA) and further identified by PCR using 5’AOX (GACTGGTTCCAATTGACAAGC) and 3’AOX (GCAAATGGCATTCTGACATCC) primers. PCR products were analyzed by electrophoresis compared with P. pastoris containing empty pPICZαA.
+ Open protocol
+ Expand
10

Silencing FAP in Adipogenic Stem Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
FAP-targeting MISSION® shRNA constructs were purchased as bacterial glycerol stocks (Sigma-Aldrich SFICLNG-NM_007986), while non-targeting control was purchased as plasmid (Sigma-Aldrich SFIC016-1EA) and introduced to competent cells. The construct labeled shFAP #1 is Sigma-Aldrich TRCN0000031326 and #2 is TRCN0000031324. Plasmid DNA was purified using Qiagen Plasmid Maxi Kits (Cat. No 12162) according to the manufacturers protocol. Lentiviral vectors were produced by triple-transfection of sh-plasmids (9μg/ml) with pCMVΔR2.8 (9μg/ml) and pMD2.G (3μg/ml) packaging vectors into FIEK293T cells. Resulting viral supernatant was titered using a p24 ELISA-based kit (Cell Biolabs, Inc. VPK-107). Primary ASCs were treated with MOI 10 viral particles and 8μg/ml polybrene overnight. 48 hours after initial exposure to viral particles, cells were either assessed for FAP expression via flow cytometry, or began adipogenic differentiation as above.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!